Institute of Kidney Lifescience Technologies

Institute of Kidney Lifescience Technologies (IKLT) is a Japanese biotechnology company focused on developing innovative regenerative medicine solutions for chronic kidney disease. Spun out from research at the Jikei University School of Medicine, the company utilizes a unique platform technology to create functional kidney tissue using mesenchymal stem cells and a specialized scaffold system. Their primary goal is to provide an alternative to dialysis and kidney transplantation by regenerating renal function through organ engineering. IKLT is currently advancing its lead programs through pre-clinical validation with the aim of addressing the global burden of end-stage renal disease.